Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VIINADIR, Yona; BRENNER, Benjamin; FUX, Liat et al.Haematologica (Roma). 2010, Vol 95, Num 11, pp 1927-1934, issn 0390-6078, 8 p.Article

Protein Z-dependent regulation of coagulationBROZE, George J.Thrombosis and haemostasis. 2001, Vol 86, Num 1, pp 8-13, issn 0340-6245Conference Paper

New anticoagulantsHIRSH, Jack; O'DONNELL, Martin; WEITZ, Jeffrey I et al.Blood. 2005, Vol 105, Num 2, pp 453-463, issn 0006-4971, 11 p.Article

The coagulation pathway and antithrombotic strategiesLEBLOND, L; WINOCOUR, P. D.Handbook of experimental pharmacology. 1999, Vol 132, pp 1-39, issn 0171-2004Article

Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitorTABATABAI, Amir; FIEHLER, Ryan; BROZE, George J et al.Thrombosis and haemostasis. 2001, Vol 85, Num 4, pp 655-660, issn 0340-6245Article

Stimulation of prothrombinase activity by the nonapeptide Thr-Trp-Ala-Arg-Asn-Ser-Tyr-Asn-Val, a segment of a plant thioninOSORIO E. CASTRO, Valdemar R; VERNON, Leo P.Peptides (New York, NY. 1980). 2003, Vol 24, Num 4, pp 515-521, issn 0196-9781, 7 p.Article

Test of the Month: The chromogenic antifactor Xa assayGEHRIE, Eric; LAPOSATA, Michael.American journal of hematology. 2012, Vol 87, Num 2, pp 194-196, issn 0361-8609, 3 p.Article

5-Amidinoindoles as dual inhibitors of coagulation factors IXa and XaBATT, Douglas G; QIAO, Jennifer X; MODI, Dilip P et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 21, pp 5269-5273, issn 0960-894X, 5 p.Article

Protease-activated receptor-2 is essential for factor viia and Xa-induced signaling, migration, and invasion of breast cancer cellsMORRIS, Dionne R; YU DING; RICKS, Tiffany K et al.Cancer research (Baltimore). 2006, Vol 66, Num 1, pp 307-314, issn 0008-5472, 8 p.Article

Recent advances in the discovery of tissue factor/factor VIIa inhibitors and dual inhibitors of factor VIIa/factor XaKRANJC, A; KIKELJ, D; PETERLIN-MASIC, L et al.Current pharmaceutical design. 2005, Vol 11, Num 32, pp 4207-4227, issn 1381-6128, 21 p.Article

Extending the pharmacokinetic half-life of coagulation factors by fusion to recombinant albuminMETZNER, Hubert J; PIPE, Steven W; WEIMER, Thomas et al.Thrombosis and haemostasis. 2013, Vol 110, Num 5, pp 931-939, issn 0340-6245, 9 p.Article

Reevaluation of some properties of fibrinogen, purified from cord blood of normal newbornsHAMULYAK, K; NIEUWENHUIZEN, W; DEVILEE, P. P et al.Thrombosis research. 1983, Vol 32, Num 3, pp 301-310, issn 0049-3848Article

Sequence of plasmin proteolysis at the NH₂-terminus of the Bβ-chain of human fibrinogenKOEHN, J. A; HURLET-JENSEN, A; NOSSEL, H. L et al.Analytical biochemistry. 1983, Vol 133, Num 2, pp 502-510, issn 0003-2697Article

Cell-free synthesis of factor VIII related proteinCHAN, V; CHAN, T. K.Thrombosis and haemostasis. 1983, Vol 50, Num 4, pp 835-837, issn 0340-6245Article

Effect of cyclic AMP and cyclic GMP on thromboplastin (factor III) synthesis in human monocytes in vitroLYBERG, T.Thrombosis and haemostasis. 1983, Vol 50, Num 4, pp 804-809, issn 0340-6245Article

Kupffer cell regulation of fibrinogen synthesis in hepatocytesSANDERS, K. D; FULLER, G. M.Thrombosis research. 1983, Vol 32, Num 2, pp 133-145, issn 0049-3848Article

5-Amidinobenzo[b]thiophenes as dual inhibitors of factors IXa and XaQIAO, Jennifer X; XUHONG CHENG; MODI, Dilip P et al.Bioorganic & medicinal chemistry letters (Print). 2005, Vol 15, Num 1, pp 29-35, issn 0960-894X, 7 p.Article

Structure and biology of tissue factor pathway inhibitorBAJAJ, Madhu S; BIRKTOFT, Jens J; STEER, Sarah A et al.Thrombosis and haemostasis. 2001, Vol 86, Num 4, pp 959-972, issn 0340-6245Article

Comparative analysis of haemostatic proteinases : Structural aspects of thrombin, factor Xa, factor IXa and protein CBODE, W; BRANDSTETTER, H; MATHER, T et al.Thrombosis and haemostasis. 1997, Vol 78, Num 1, pp 501-511, issn 0340-6245Conference Paper

SYMPOSIUM ON FIBRINOGEN AND DISFIBRINOGENEMIA.1978; BIBL. HAEMATOL.; CHE; DA. 1978; NO 44; PP. 105-173; BIBL. DISSEM.Article

ROLE OF MACROMOLECULAR BINDING SITE OF THROMBIN MOLECULE IN EXCITATION OF ANTICOAGULATION SYSTEMSTRUKOVA SM; UMAROVA BA; MITROSHINA TN et al.1982; THROMBOSIS RESEARCH; ISSN 0049-3848; USA; DA. 1982; VOL. 26; NO 4; PP. 259-266; BIBL. 16 REF.Article

Evidence and desperation in off-label prescribing: recombinant factor VllaLIPWORTH, Wendy; KERRIDGE, Ian; LITTLE, Miles et al.BMJ (Overseas and retired doctors ed.). 2012, Vol 344, Num 7840, pp 26-28, issn 1759-2151, 3 p.Article

An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasmaSAMAMA, Meyer Michel; AMIRAL, Jean; GUINET, Céline et al.Thrombosis and haemostasis. 2010, Vol 104, Num 5, pp 1078-1079, issn 0340-6245, 2 p.Article

Recombinant coagulation factor VIIa - from molecular to clinical aspects of a versatile haemostatic agentPERSSON, Egon; BOLT, Gert; STEENSTRUP, Thomas D et al.Thrombosis research. 2010, Vol 125, Num 6, pp 483-489, issn 0049-3848, 7 p.Article

Reversal of a potent investigational anticoagulant : Idraparinux with recombinant factor VIIADAO, Andrew; TUAN, Bertrand; CARLSON, Nicole et al.The American journal of medicine. 2005, Vol 118, Num 10, pp 1172-1173, issn 0002-9343, 2 p.Article